Paul hudson (born 14 october 1967) [2] is a british businessman, and the chief executive (ceo) of sanofi, the world's fifth largest pharmaceutical company by prescription drug sales. Leadership in innovation and impact I am proud to lead sanofi, a global healthcare company driven by one purpose We chase the miracles of science to improve people’s lives That means our teams are dedicated to transforming the. He’s a vocal advocate for the technology and its great potential
Working with external ai partners, he’s pushing sanofi to become the ai leader in its industry. Sanofi ceo paul hudson speaks during the competing in the global marketplace Strategies for growth panel, at the fortune global forum on nov 11, 2024 in new york city. Sanofi announced last year that it was going “all in on ai.” for hudson, that means integrating ai across sanofi’s value chain. Sanofi ceo paul hudson joins 'squawk box' to discuss the company's plan to become an immunology powerhouse, drug pipeline outlook, using ai for future drug discoveries, and more.more
As the chief executive officer (ceo) of sanofi, a leading global biopharmaceutical company, hudson has been instrumental in steering the organization toward innovation and growth His extensive career spans over 25 years, encompassing pivotal roles across the united states, europe, and asia.
OPEN
